Insider filing · TRVI
Michael Thomas Heffernan
Director
profile →
Trevi Therapeutics, Inc.
TRVI · Healthcare · 2 filings in 24 months
ticker →
Michael Thomas Heffernan sold $593K of Trevi Therapeutics (TRVI)
Executed Sep 15, disclosed Sep 17, 2 days later.
Value, as filed
$593K
39,273 sh across 2 lots
Executed
Sep 15
the trade date, as filed
Disclosed
Sep 17
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MHMichael Thomas Heffernan (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Trevi Therapeutics, Inc. (TRVI). The largest single filing was $593K of TRVI (39,273 sh across 2 lots, as filed), executed Sep 15.
The name
TRVIHealthcare · Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes investigational therapy for the treatment…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→